IMS: Sexual wellbeing after menopause Banner

Category: early menopause

IMS: Sexual wellbeing after menopause

Patient Support Material: Free yourself and embrace positive sexual wellbeing Sexual health is a state of physical, emotional, mental and social wellbeing related to… Continue Reading →

Read more

Share your opinions as a woman with POI/ Premature menopause.

International POI guideline update survey What matters for you? A 10 minute scoping survey for women or for health professionals: An international collaboration between the European… Continue Reading →

Read more

Share your opinions as a woman with POI/ Premature menopause.

International POI guideline update survey What matters for you? A 10 minute scoping survey for women or for health professionals: An international collaboration between the European… Continue Reading →

Read more

IMS: Sexual wellbeing after menopause

Free yourself and embrace positive sexual wellbeing Sexual health is a state of physical, emotional, mental and social wellbeing related to sexuality. After menopause… Continue Reading →

Read more
Jean Hailes: National Women’s Health Survey thumbnail
Categories: ,

Jean Hailes: National Women’s Health Survey

National Women’s Health Survey Welcome to Jean Hailes survey This survey was developed by Jean Hailes for Women’s Health and a team of experts…. Continue Reading →

Read more

Jean Hailes: National Women’s Health Survey

National Women’s Health Survey Welcome to Jean Hailes survey This survey was developed by Jean Hailes for Women’s Health and a team of experts…. Continue Reading →

Read more

The Menopause Charity launches in the UK

Menopause specialist Dr Louise Newson has launched a new Crowdfunding campaign for The Menopause Charity, which she hopes will change millions of women’s lives… Continue Reading →

Read more

TGA accepts AndroFeme 1 for evaluation in postmenopausal women with Hypoactive Sexual Desire Dysfunction.

TGA accepts AndroFeme 1 for evaluation in postmenopausal women with HSDD. Perth, Western Australia; Dec. 05, 2019  — Lawley Pharmaceuticals today announced AndroFeme 1,… Continue Reading →

Read more

TGA accepts Lawley product for evaluation in postmenopausal women with HSDD.

TGA accepts Lawley product for evaluation in postmenopausal women with HSDD. Perth, Western Australia; Dec. 05, 2019  — Lawley Pharmaceuticals Pty Ltd today announced… Continue Reading →

Read more

Global Consensus Position Statement on the Use of Testosterone Therapy for Women

The Global Consensus Position Statement on the Use of Testosterone Therapy for Women was simultaneously published on the 2nd September 2019 in Maturitas, Journal… Continue Reading →

Read more